Zimmer Biomet discloses FCPA deals with DOJ, SEC
( January 12, 2017, 18:42 GMT | Official Statement) -- MLex Summary: Zimmer Biomet Holdings announced reaching agreements totaling $30.5 million with the Department of Justice and the Securities and Exchange Commission to resolve allegations that Biomet continued to engage in conduct that violated the Foreign Corrupt Practices Act after it entered into a deferred prosecution agreement in 2012. Zimmer acquired Biomet in 2015, and the company noted that an independent monitor that it must engage pursuant to the new deferred prosecution agreement will focus on the legacy Biomet operations. Statement follows below:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.